Jay T. Evans
Fondateur chez Inimmune Corp.
Profil
Jay T.
Evans is the founder of Inimmune Corp.
(founded in 2016), where he holds the titles of President, Chief Executive Officer & Director.
He is currently a Director at Biotechnology Innovation Organization (since 2017) and The Montana Bioscience Alliance (since 2017).
Dr. Evans has a graduate degree from Oregon State University and an undergraduate degree from Pacific Lutheran University.
Postes actifs de Jay T. Evans
| Sociétés | Poste | Début |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | 14/09/2017 |
The Montana Bioscience Alliance
 The Montana Bioscience Alliance Miscellaneous Commercial ServicesCommercial Services The Montana Bioscience Alliance serves as a hub for Montana’s biotechnology companies, entrepreneurs, laboratories, hospitals, clinics and universities to commercialize grow and sustain globally competitive bioscience companies. It Serve as the interface between the life sciences cluster and state government to help implement and improve the state’s life sciences cluster development strategy. The company was founded in 2004 and is headquartered in Billings, MT. | Directeur/Membre du Conseil | 19/09/2017 |
Inimmune Corp.
 Inimmune Corp. BiotechnologyHealth Technology Inimmune Corp. operates as a biotechnology company that focuses on the discovery, optimization, and development of new innate immune receptor agonists and antagonists to treat a wide array of medical conditions including allergy, autoimmune diseases and cancer. The company was founded by Jay T. Evans, David J. Burkhart, Helene Bazin-Lee, and Kendall Ryter in 2016 and is headquartered in Missoula, MT. | Fondateur | 01/01/2016 |
Formation de Jay T. Evans
| Oregon State University | Graduate Degree |
| Pacific Lutheran University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
The Montana Bioscience Alliance
The Montana Bioscience Alliance Miscellaneous Commercial ServicesCommercial Services The Montana Bioscience Alliance serves as a hub for Montana’s biotechnology companies, entrepreneurs, laboratories, hospitals, clinics and universities to commercialize grow and sustain globally competitive bioscience companies. It Serve as the interface between the life sciences cluster and state government to help implement and improve the state’s life sciences cluster development strategy. The company was founded in 2004 and is headquartered in Billings, MT. | Commercial Services |
Inimmune Corp.
Inimmune Corp. BiotechnologyHealth Technology Inimmune Corp. operates as a biotechnology company that focuses on the discovery, optimization, and development of new innate immune receptor agonists and antagonists to treat a wide array of medical conditions including allergy, autoimmune diseases and cancer. The company was founded by Jay T. Evans, David J. Burkhart, Helene Bazin-Lee, and Kendall Ryter in 2016 and is headquartered in Missoula, MT. | Health Technology |
